Insulin-Like Growth Factors in the Gastrointestinal Tract and Liver

被引:51
作者
Kuemmerle, John F. [1 ,2 ,3 ]
机构
[1] Virginia Commonwealth Univ, Dept Med, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Div Gastroenterol, Richmond, VA 23298 USA
关键词
IGF; IGF binding proteins; Growth hormone; Gastrointestinal tract; Liver; FACTOR-I RECEPTOR; MESSENGER RIBONUCLEIC-ACIDS; HUMAN INTESTINAL MUSCLE; HEPATIC STELLATE CELLS; ENDOGENOUS IGF-I; BINDING-PROTEINS; SMALL-BOWEL; ENHANCED GROWTH; INHIBITS GROWTH; FACTOR SYSTEM;
D O I
10.1016/j.ecl.2012.04.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The liver is a major source of insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) that are present in the circulation and have important endocrine activities relating to energy metabolism, body size, carcinogenesis, and various organ-specific functions. Although IGFs have only minor effects on the normal liver itself, production of IGFs and IGFBPs in a tissue-specific manner in the gastrointestinal tract exert important regulatory effects on cellular proliferation, survival, and apoptosis. IGFs and IGFBPs play important regulatory roles in the response of both the liver and the gastrointestinal tract to inflammation and in the development of neoplasia.
引用
收藏
页码:409 / +
页数:16
相关论文
共 102 条
  • [1] ABBOTT AM, 1992, J BIOL CHEM, V267, P10759
  • [2] INSULIN-LIKE GROWTH FACTOR-I MESSENGER RIBONUCLEIC-ACIDS WITH ALTERNATIVE 5'-UNTRANSLATED REGIONS ARE DIFFERENTIALLY EXPRESSED DURING DEVELOPMENT OF THE RAT
    ADAMO, M
    LOWE, WL
    LEROITH, D
    ROBERTS, CT
    [J]. ENDOCRINOLOGY, 1989, 124 (06) : 2737 - 2744
  • [3] Berg KM, 2007, GASTROENTEROLOGY, V132, pA
  • [4] Actions and interactions of growth hormone and insulin-like growth factor-II: Body and organ growth of transgenic mice
    Blackburn, A
    Schmitt, A
    Schmidt, P
    Wanke, R
    Hermanns, W
    Brem, G
    Wolf, E
    [J]. TRANSGENIC RESEARCH, 1997, 6 (03) : 213 - 222
  • [5] BROWN AL, 1986, J BIOL CHEM, V261, P3144
  • [6] Orally administered IGF-I increases intestinal mucosal growth in formula-fed neonatal pigs
    Burrin, DG
    Wester, TJ
    Davis, TA
    Amick, S
    Heath, JP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1996, 270 (05) : R1085 - R1091
  • [7] INSULIN-LIKE GROWTH-FACTOR-I IN HUMAN GASTROINTESTINAL EXOCRINE SECRETIONS
    CHAURASIA, OP
    MARCUARD, SP
    SEIDEL, ER
    [J]. REGULATORY PEPTIDES, 1994, 50 (02) : 113 - 119
  • [8] INSULIN-LIKE GROWTH-FACTOR-I PREVENTS GUT ATROPHY AND MAINTAINS INTESTINAL INTEGRITY IN SEPTIC RATS
    CHEN, K
    OKUMA, T
    OKAMURA, K
    TABIRA, Y
    KANEKO, H
    MIYAUCHI, Y
    [J]. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1995, 19 (02) : 119 - 124
  • [9] Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer
    Cheng, Yu-Wei
    Idrees, Kamran
    Shattock, Richard
    Khan, Sajid A.
    Zeng, Zhaoshi
    Brennan, Cameron W.
    Paty, Philip
    Barany, Francis
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (03) : 568 - 577
  • [10] MODULATION OF EPIDERMAL GROWTH FACTOR-INDUCED CELL-PROLIFERATION AND RECEPTOR-BINDING BY INSULIN IN CULTURED INTESTINAL EPITHELIAL-CELLS
    CONTEAS, CN
    MCMORROW, B
    LUK, GD
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) : 414 - 419